Can I Buy Amgen Inc Shares in India?

Yes, Amgen Inc shares can be bought in India by opening an international trading account with Groww.

How to Buy Amgen Inc Shares in India?

One can easily invest in Amgen Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Amgen Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Amgen Inc.

What is the Share Price of Amgen Inc?

The share price of Amgen Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Amgen Inc share price is $272.11 as of 21 Jan ‘25

What is the Market Cap of Amgen Inc?

The Amgen Inc market cap is $146.26B as of 21 Jan ‘25

What is the PE and PB ratio of Amgen Inc?

The PE and PB ratio of Amgen Inc is 34.6 and 19.4 as of 21 Jan ‘25

Amgen Inc Share Price, AMGN Stock Price Quote Today

<img alt="Amgen Inc" srcSet="https://assets-netstorage.groww.in/intl-stocks/logos/AMGN.png 1x, https://assets-netstorage.groww.in/intl-stocks/logos/AMGN.png 2x" src="https://assets-netstorage.groww.in/intl-stocks/logos/AMGN.png" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="companyLogo_companyImage__bT0On absolute-center uspp14Logo" loading="lazy"/>
Amgen Inc Healthcare 
$272.11
+2.68(0.99%) 1D
1D
1W
1M
1Y
3Y
5Y
Performance
Open PricePrev. CloseVolumeAvg. Volume
$276.97$272.112,0673,570,053
FundamentalsMarket Cap$146.26B
P/B Ratio19.4
P/E Ratio34.6
Enterprise Value$197.65B
Div. Yield3.50%
Book Value14.31
EPS(TTM)3.23
ROENA
Understand Fundamentals
FUNDAMENTALS
It is financial information that is reported quarterly or annually.
Market Cap
Market cap or market capitalization is the total market value of all of a company's outstanding shares.
Div. Yield
The divided yield displayed as a percentage is the amount of money a company pays shareholders for owning a share of its stock divided by its current stock price
P/B Ratio
The price-to-book ratio is a company's current market price to its Book Value. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock.
Book Value
The book value of a stock is theoretically the amount of money that would be paid to shareholders if the company was liquidated and paid off all of its liabilities.
P/E Ratio
The price-earnings ratio is a company's share price to the company's Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued.
EPS(TTM)
Earnings per share (EPS) is a company's net profit divided by the number of common shares it has outstanding. EPS indicates how much money a company makes for each share of its stock, and is widely used metric to estimate corporate value
Enterprise Value
Enterprise Value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
ROE
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholder's equity
About the CompanyAmgen, Inc. is a multinational biopharmaceutical company headquartered in California, United States. It was established in the year 1980 as Applied Molecular Genetics, Inc. AMGN shares began trading on the Nasdaq Stock Market in 1983. As of 2020, the company ranked 162nd on Forbes’ list of Global 2000 and 135th on the Fortune 500. Forbes also named Amgen in its Just 100 2021– the list of 100 companies leading a new era of responsible capitalism. Amgen’s net worth is valued at $136.81 billion in 2020.
AMGN is one of the world’s leading biotechnology companies, with a history of developing medications for serious and fatal illnesses. In 1989, Amgen received approval by the US Food and Drug Administration (FDA) for its product - Epogen. Epogen is used to treat anaemia caused by treatment with certain HIV drugs, chemotherapy for cancer, and chronic kidney failure. In 1991, FDA approved its drug Neupogen, which prevents infections in cancer patients undergoing chemotherapy. The company acquired Immunex Corporation in a $16 billion deal in 2009. With this acquisition, Amgen added Enbrel to its drug portfolio, the first drug for rheumatoid arthritis. Amgen stock made a significant jump of 2.8% to $241.60 on November 11th 2020, after its drug – Tezepelumab scored a Phase III win in the treatment of severe and uncontrolled asthma. In addition to innovative medicines, the company also undertakes transformative research and biologics manufacturing. 
Amgen’s migraine treatment was named as one of the Best Inventions of 2018 by TIME Magazine. In 2019, Amgen scored a perfect 100% on Human Rights Campaign Foundation’s Corporate Equality Index. That year, it was also named as one of the happiest companies in America by CareerBliss, for the fourth consecutive year. Amgen also holds a Guinness World Record for most osteoporosis screenings in a day. Amgen Foundation, its philanthropic entity, seeks to enrich communities by advancing excellence in science education, social services, environmental programs, culture and arts.;
OrganisationAmgen Inc
IndustryDrug Manufacturers—General
HeadQuartersThousand Oaks, CA
Company Financials
*All values are in Million $
No Graph Data To Display
Quarterly
Yearly
See Details
Similar StocksCOMPANYMARKET PRICECLOSE PRICEMARKET CAP

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsMTFIPOMutual FundsNFOETFCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and SupportTrust and Safety
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemapWeb Stories
ⓒ 2016-2025 Groww. All rights reserved, Built with ♥in India

Open Price	Prev. Close	Volume	Avg. Volume
$276.97	$272.11	2,067	3,570,053

Market Cap	$146.26B
P/B Ratio	19.4
P/E Ratio	34.6
Enterprise Value	$197.65B

Organisation	Amgen Inc
Industry	Drug Manufacturers—General
HeadQuarters	Thousand Oaks, CA